BGIM
OGN icon

Boussard & Gavaudan Investment Management’s Organon & Co OGN Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-17,173
Closed -$529K – 144
2021
Q2 		$529K Buy
+17,173
New +$565K 0.05% 59

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boussard & Gavaudan Investment Management's OGN Position: Q3 2021 in Review

Boussard & Gavaudan Investment Management sold out of Organon & Co (OGN) in Q3 2021, closing a stake of 17,173 shares — an estimated $529K sold.

Boussard & Gavaudan Investment Management first reported a position in OGN in Q2 2021 and held it in 1 quarter. The position peaked at $529K in Q2 2021. 928 funds tracked by Wall St. Rank hold OGN as of Q3 2021.

  • Boussard & Gavaudan Investment Management reported no remaining Organon & Co position as of Q3 2021 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 17,173 Organon & Co shares in Q3 2021, an estimated $529K.
  • Boussard & Gavaudan Investment Management first reported a position in Organon & Co in Q2 2021 and held it in 1 quarter.
  • Boussard & Gavaudan Investment Management's Organon & Co position peaked at $529K in Q2 2021.
  • 928 funds tracked by Wall St. Rank held Organon & Co as of Q3 2021.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q3 2021, filed 8 Nov 2021.